Effects of once-weekly semaglutide vs canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 trial

被引：0
|
作者：
McCrimmon, R. J. [1 ]
Catarig, A. [2 ]
Frias, J. P. [3 ]
Lausvig, N. L. [2 ]
le Roux, C. W. [4 ]
Thielke, D. [2 ]
Lingvay, I. [5 ]
机构：
[1] Univ Dundee, Dundee, Scotland
[2] Novo Nordisk AS, Soborg, Denmark
[3] Natl Res Inst, Los Angeles, CA USA
[4] Univ Coll Dublin, Dublin, Ireland
[5] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
54
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of semaglutide once-weekly vs placebo as add-on to basal insulin alone or in combination with metformin in subjects with Type 2 diabetes (SUSTAIN 5)
    Rodbard, H.
    Lingvay, I.
    Reed, J.
    de la Rosa, R.
    Rose, L.
    Sugimoto, D.
    Araki, E.
    Chu, P-L
    Wijayasingh, N.
    Norwood, P.
    Subramanian, G.
    DIABETIC MEDICINE, 2017, 34 : 145 - 146
  • [32] Efficacy and Safety of Once-Weekly Semaglutide vs. Sitagliptin as Add-on to Metformin and/or Thiazolidinediones after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 2)
    Ahren, Bo
    Comas, Luis Masmiquel
    Kumar, Harish
    Sargin, Mehmet
    Karsbol, Julie Derving
    Jacobsen, Sanja Hald
    Chow, Francis
    DIABETES, 2016, 65 : A48 - A48
  • [33] Once-weekly exenatide in type 2 diabetes
    Dinesh M. Parmar
    Shilpa P. Jadav
    International Journal of Diabetes in Developing Countries, 2011, 31 : 121 - 122
  • [34] Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide
    Berry, Sasha
    Chubb, Barrie
    Acs, Annabel
    Falla, Edel
    Verma, Akanksha
    Malkin, Samuel J. P.
    Hunt, Barnaby
    Palmer, Andrew J.
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1019 - 1031
  • [35] Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index
    Yabe, Daisuke
    Yamada, Yuichiro
    Kaku, Kohei
    Nishida, Tomoyuki
    Sato, Toshihiro
    Seino, Yutaka
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (07) : 1161 - 1174
  • [36] Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
    Hunt, Barnaby
    Malkin, Samuel J. P.
    Moes, Robert G. J.
    Huisman, Eline L.
    Vandebrouck, Tom
    Wolffenbuttel, Bruce H. R.
    BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [37] Once-weekly exenatide in type 2 diabetes
    Parmar, Dinesh M.
    Jadav, Shilpa P.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2011, 31 (02) : 121 - 122
  • [38] Study Design and Baseline Profile for Patients with Type 2 Diabetes in the Semaglutide Once-Weekly Randomized Pragmatic Trial (SEPRA)
    Willey, Vincent
    Buse, John B.
    Harty, Brian
    Mitchell, Julie L.
    Soule, Benjamin P.
    Christensen, Helene N.
    Cziraky, Mark J.
    Skibsted, Simon
    DIABETES, 2022, 71
  • [39] Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
    Petri, Kristin Cecilie Carlsson
    Ingwersen, Steen Hvass
    Flint, Anne
    Zacho, Jeppe
    Overgaard, Rune Viig
    DIABETES THERAPY, 2018, 9 (04) : 1533 - 1547
  • [40] Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    Aroda, Vanita
    Bain, Stephen
    Cariou, Bertrand
    Piletic, Milivoj
    Rose, Ludger
    Bergan, Eirik Quamme
    Zacho, Jeppe
    Devries, J. Hans
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S51 - S51
12345